B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Cabozantinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cabozantinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

tivozanib
22 shared targets
glesatinib
15 shared targets
golvatinib
20 shared targets
bms
15 shared targets
cep
18 shared targets
mk
13 shared targets
lenvatinib
14 shared targets
regorafenib
15 shared targets
motesanib
18 shared targets
saracatinib
19 shared targets
Loading evidence profile...

This evidence profile for Cabozantinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.